Focusing on Good Responders to Pneumococcal Polysaccharide Vaccination in General Hospital Patients Suspected for Immunodeficiency. A Decision Tree Based on the 23-Valent Pneumococcal IgG Assay

Background and Aim: Recently, the 23-valent IgG-assay was suggested as screening assay to identify poor responders to pneumococcal polysaccharide (PnPS)-vaccination with the serotype-specific assay as a second-line test. However, in a low pre-test probability general hospital setting predicting good...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Lisanne M. A. Janssen, Michiel Heron, Jean-Luc Murk, Alexander C. A. P. Leenders, Ger T. Rijkers, Esther de Vries
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2019-11-01
Rangatū:	Frontiers in Immunology
Ngā marau:	primary immunodeficiency humoral immunodeficiency pneumococcal polysaccharide response serotype-specific assay polysaccharide response pneumococcal vaccination response
Urunga tuihono:	https://www.frontiersin.org/article/10.3389/fimmu.2019.02496/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!